Inj., triluron, 1 mg
Products billed under this code include Triluron.
Payment limit per 1 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Triluron.
Payment limit per 1 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Triluron | Fidia Pharma USA Inc | 89122-0879-01 | 20 | $203.76 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $10.188 | −$0.242 | 1 MG | Inj., triluron, 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $10.43 | −$0.115 | 1 MG | Inj., triluron, 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $10.545 | +$0.426 | 1 MG | Inj., triluron, 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $10.119 | −$0.15 | 1 MG | Inj., triluron, 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $10.269 | +$0.105 | 1 MG | Inj., triluron, 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $10.164 | −$0.117 | 1 MG | Inj., triluron, 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $10.281 | +$0.187 | 1 MG | Inj., triluron, 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $10.094 | −$0.262 | 1 MG | Inj., triluron, 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $10.356 | +$0.17 | 1 MG | Inj., triluron, 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $10.186 | −$0.302 | 1 MG | Inj., triluron, 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $10.488 | +$0.218 | 1 MG | Inj., triluron, 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $10.27 | −$0.068 | 1 MG | Inj., triluron, 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $10.338 | +$0.283 | 1 MG | Inj., triluron, 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $10.055 | +$0.152 | 1 MG | Inj., triluron, 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $9.903 | +$0.098 | 1 MG | Inj., triluron, 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $9.805 | −$0.156 | 1 MG | Inj., triluron, 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $9.961 | +$0.152 | 1 MG | Inj., triluron, 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $9.809 | – | 1 MG | Inj., triluron, 1 mg | v1, posted June 9, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.